CD247 and neoplasm: Anti‐tumour activity of chNKG2D/CD3ζ‐wtDap10 T cells was further demonstrated by the significant reduction in tumour burden in both a Rae‐1β+ subcutaneous [11] and systemic lymphoma model [44], without prior lymphodepleting chemotherapy.